- Home
- MMA vs ALLR Comparison
MMA vs ALLR Comparison
Compare MMA & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMA
- ALLR
- Stock Information
- Founded
- MMA 2013
- ALLR 2004
- Country
- MMA Australia
- ALLR United States
- Employees
- MMA N/A
- ALLR N/A
- Industry
- MMA
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- MMA
- ALLR Health Care
- Exchange
- MMA Nasdaq
- ALLR Nasdaq
- Market Cap
- MMA 20.2M
- ALLR 20.2M
- IPO Year
- MMA 2024
- ALLR N/A
- Fundamental
- Price
- MMA $1.36
- ALLR $1.30
- Analyst Decision
- MMA
- ALLR Strong Buy
- Analyst Count
- MMA 0
- ALLR 1
- Target Price
- MMA N/A
- ALLR $9.25
- AVG Volume (30 Days)
- MMA 160.7K
- ALLR 203.6K
- Earning Date
- MMA 01-01-0001
- ALLR 11-14-2025
- Dividend Yield
- MMA N/A
- ALLR N/A
- EPS Growth
- MMA N/A
- ALLR N/A
- EPS
- MMA N/A
- ALLR N/A
- Revenue
- MMA $739,641.00
- ALLR N/A
- Revenue This Year
- MMA N/A
- ALLR N/A
- Revenue Next Year
- MMA N/A
- ALLR N/A
- P/E Ratio
- MMA N/A
- ALLR N/A
- Revenue Growth
- MMA 191.30
- ALLR N/A
- 52 Week Low
- MMA $0.60
- ALLR $0.61
- 52 Week High
- MMA $3.07
- ALLR $2.35
- Technical
- Relative Strength Index (RSI)
- MMA 49.99
- ALLR 53.02
- Support Level
- MMA $1.05
- ALLR $0.99
- Resistance Level
- MMA $1.20
- ALLR $1.17
- Average True Range (ATR)
- MMA 0.11
- ALLR 0.10
- MACD
- MMA -0.01
- ALLR 0.02
- Stochastic Oscillator
- MMA 55.97
- ALLR 93.89
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.